Melissa Prah

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes”.

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.06.020

N/A

0DataRank · unranked

27 citations

Melissa Prah, Amber A. Retzlaff, Kathleen M. Schmainda, Jennifer Connelly, Scott D. Rand +5 more

Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial

Neuro-Oncology(2020)10.1093/neuonc/noaa167

N/A

0DataRank · unranked

28 citations

Melissa Prah, Helga S. Marques, Eun Hee Kim, Daniel P. Barboriak, Jerrold L. Boxerman +1 more

Magnetic Resonance Imaging Mapping of Brain Tumor Burden: Clinical Implications for Neurosurgical Management: Case Report

Neurosurgery Practice(2021)10.1093/neuopn/okab029

N/A

0DataRank · unranked

16 citations

Melissa Prah, Fernando Santos-Pinheiro, Wade M. Mueller, Elizabeth J. Cochran, Kathleen M. Schmainda +1 more

Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma

Frontiers in Oncology(2022)10.3389/fonc.2022.1066191

N/A

0DataRank · unranked

6 citations

Fernando Santos-Pinheiro, Michael Straza, Melissa Prah, Wade M. Mueller, Max Krucoff +8 more

A cross-sectional study to test equivalence of low- versus intermediate-flip angle dynamic susceptibility contrast MRI measures of relative cerebral blood volume in patients with high-grade gliomas at 1.5 Tesla field strength

Frontiers in Oncology(2023)10.3389/fonc.2023.1156843

N/A

0DataRank · unranked

6 citations

Dane Weinert, Steven Cen, Bino Varghese, Timothy Dondlinger, Melissa Prah +26 more

Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma

Frontiers in Oncology(2024)10.3389/fonc.2023.1278157

N/A

0DataRank · unranked

9 citations

Robert Wujek, Hisham Alhajala, Jonathan M. Cobb, Melissa Prah, Ninh Doan +4 more

Application of Delta T1 Maps for Quantitative and Objective Assessment of Extent of Resection and Survival Prediction in Glioblastoma

Neurosurgery Open(2024)10.1227/neuprac.0000000000000077

N/A

0DataRank · unranked

3 citations

Melissa Prah, Benjamin Best, Max Krucoff, Wade M. Mueller, Kathleen M. Schmainda +1 more

Identification of a Single-Dose, Low-Flip-Angle–Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma

American Journal of Neuroradiology(2024)10.3174/ajnr.a8357

N/A

0DataRank · unranked

1 citations

Ashley M. Stokes, John P. Karis, Laura C. Bell, Jennifer Eschbacher, Kristofer Jennings +6 more